About this course
Stroke prevention is one of the cornerstones in the management of patients with atrial fibrillation (AF). AF increases stroke risk and is prevented using vitamin K antagonists or non-vitamin K antagonist oral anticoagulants (NOACs). The use of NOACs has led to improved clinical outcomes in AF patients in terms of stroke prevention. This e-learning module summarizes the data on the efficacy and safety of NOACs, their guidelines-based indications, and the reversal agents for NOAC-induced bleeding.
Upon completion of the educational activity, health care providers should be able to:
- Identify potential NOACs for specific patients
- Identify reversal agents for NOAC-induced bleeding
- Stroke risk stratification
- Vitamin K antagonists versus NOACs
- The four approved NOACs
- NOACs in the guidelines
- Specific, non-specific, and emerging reversal agents
- Patient specific indications for using each NOAC
- Acceptability, accessibility, and affordability of NOACs
1 CME Point Available
A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.